Postmarketing surveillance of adverse drug reactions.
作者信息
Castle W M, Lewis J A
出版信息
Br Med J (Clin Res Ed). 1984 May 12;288(6428):1458-9. doi: 10.1136/bmj.288.6428.1458-b.
Abstract
摘要
相似文献
1
Postmarketing surveillance of adverse drug reactions.药品不良反应的上市后监测
Br Med J (Clin Res Ed). 1984 May 12;288(6428):1458-9. doi: 10.1136/bmj.288.6428.1458-b.
2
Techniques of postmarketing surveillance. An overview.上市后监测技术。概述。
Med Toxicol. 1986 Jul-Aug;1(4):237-46. doi: 10.1007/BF03259840.
3
Postmarketing surveillance of adverse reactions to drugs.药品不良反应的上市后监测。
Br Med J (Clin Res Ed). 1984 Mar 24;288(6421):879-80. doi: 10.1136/bmj.288.6421.879.
4
Monitoring of drugs after marketing.药品上市后监测
J R Coll Gen Pract. 1983 Jul;33(252):438-41.
5
Postmarketing surveillance of adverse reactions to drugs.药品不良反应的上市后监测。
Br Med J (Clin Res Ed). 1984 Apr 14;288(6424):1155-6. doi: 10.1136/bmj.288.6424.1155.
6
Postmarketing surveillance of adverse drug reactions: problems and solutions.药品不良反应的上市后监测：问题与解决方案
CMAJ. 1986 Jul 1;135(1):27-32.
7
Adverse drug reactions.
Hum Toxicol. 1986 May;5(3):161-2.
8
Adverse reactions to new drugs.新药的不良反应。
Br Med J (Clin Res Ed). 1983 Mar 26;286(6370):1052-3. doi: 10.1136/bmj.286.6370.1052.
9
Better reporting of adverse drug reactions.
Ann Intern Med. 1985 Feb;102(2):264-5. doi: 10.7326/0003-4819-102-2-264.
10
[Problems of the number of cases in drug surveillance].[药物监测中的病例数问题]
Rev Med Interne. 1986 Nov;Spec No:45-51.
本文引用的文献
1
Problems of post-marketing surveillance.上市后监测问题。
Br J Clin Pharmacol. 1983 Dec;16(6):581-5. doi: 10.1111/j.1365-2125.1983.tb02225.x.
Zotero 插件